Optimizing outcomes in refractory epilepsy with VNS Therapy®
LivaNova Neuromodulation firmly believes the adoption of VNS Therapy is of major importance if we are to improve the quality of life of patients suffering from drug-resistant epilepsy.
To achieve this, we strive to provide high quality education and training by experienced VNS Therapy physicians to healthcare professionals interested in incorporating VNS Therapy into their practice.
Led by paediatric
2 epilepsy experts ,
this interactive conference will educate clinicians about how to
introduce VNS Therapy to patients as a treatment option and how to
optimise VNS Therapy dosing.
Meeting goals
The goal of this conference is to enhance your confidence in the use of VNS Therapy as a part of a comprehensive approach to the treatment of this life-long disorder.
The key elements of the agenda will be:
Meeting goals
The goal of this conference is to enhance your confidence in the use of VNS Therapy as a part of a comprehensive approach to the treatment of this life-long disorder.
The key elements of the agenda will be:
- ILAE consensus guidelines for defining drug-resistant epilepsy
- VNS Therapy Overview and AspireSR
- The scientific rationale behind dosing parameters
- Interactive case study discussions & hands-on dosing workshop
At the end of Friday’s session there will be a hands-on VNS Therapy workshop.
